Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

29.00
-0.3000-1.02%
Post-market: 29.020.0201+0.07%19:59 EDT
Volume:10.08M
Turnover:294.56M
Market Cap:6.77B
PE:-46.55
High:30.61
Open:30.08
Low:28.55
Close:29.30
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:1.15
T/O Rate:4.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:20.88
PE(LYR):56.61

Loading ...

Movement Alert|Hims & Hers Health Rises 5.12% in Regular Trading, Director Share Purchases Boost Market Confidence

Market Focus
·
May 27

Stock Track | Hims & Hers Health Soars 5.20% Intraday as Board Member Boosts Stake Amid Stock Rout

Stock Track
·
May 27

BUZZ-U.S. STOCKS ON THE MOVEd-Micron, Abercrombie & Fitch, Q32 Bio

Reuters
·
May 27

BUZZ-U.S. STOCKS ON THE MOVE-MGM, Hims & Hers, Semtech

Reuters
·
May 27

BUZZ-Hims & Hers rises as board member boosts stake amid stock rout

Reuters
·
May 27

Hims & Hers Health Shares up 2.2% Premarket; Board Member David Wells Buys Nearly $1.2 Mln in Stock

THOMSON REUTERS
·
May 27

Can Hims & Hers (HIMS) Canadian GLP-1 Push Redefine Its Long-Term Profitability Playbook?

Simply Wall St.
·
May 27

Hims & Hers director David B. Wells reports purchase of 48,400 shares for $1.17 million

Reuters
·
May 27

Hims & Hers Health Is Maintained at Neutral by B of A Securities

Dow Jones
·
May 27

Moderately bullish activity in Hims and Hers Health with shares down 0.32%

TIPRANKS
·
May 27

BUZZ-BofA says Hims & Hers 2026 revenue target hinges on GLP-1 growth, lowers PT

Reuters
·
May 26

Does Medicine's New Obsession Really Work? -- Barrons.com

Dow Jones
·
May 26

BofA Adjusts Price Target on Hims & Hers Health to $25 From $28

MT Newswires Live
·
May 26

Hims & Hers : Bofa Global Research Cuts Price Objective to $25.00 From $28.00

THOMSON REUTERS
·
May 26

Does Medicine's New Obsession Really Work? -- Barron's

Dow Jones
·
May 23

Hims & Hers Health Is Maintained at Hold by Truist Securities

Dow Jones
·
May 22

Truist Adjusts Price Target on Hims & Hers Health to $23 From $18, Maintains Hold Rating

MT Newswires Live
·
May 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

TIPRANKS
·
May 22

YieldMax HIMS ETF Declares Weekly Dividend of $0.2186 Per Share

Deep News
·
May 22

Moderately bullish activity in Hims and Hers Health with shares up 3.78%

TIPRANKS
·
May 22